About Accrete Pharma
Accrete Pharma is a Healthcare company based in Hyderabad (India) founded in 2007 by DN Mohan Reddy. It manufactures bulk drug intermediates for oncology pharmaceuticals in India. It operates on a B2B model. The company has 52 employees. Its Indian entity Accrete Pharmaceuticals Private Limited reported revenue of ₹41.49 Cr. Accrete Pharma offers products and services including Pazopanib Intermediates, Ibrutinib Intermediates, Imatinib Intermediates, and Lenalidomide Intermediates. Its focus areas include Research and Development, Biotech Innovation, Product Development and Pharmaceuticals. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Accrete Pharmaceuticals Private Limited is an ISO-certified company that produces bulk drug intermediates, primarily for anti-cancer products. Based in Hyderabad, India, they focus on quality manufacturing, proper documentation, and customer satisfaction in the pharmaceutical industry. They operate a cGMP-compliant facility and prioritize advanced technologies for product development, supplying intermediates to other pharma companies while maintaining environmental standards.
- Headquarters Hyderabad, India
- Employees 52
- Founders DN Mohan Reddy
- SectorsHealthcare
- Email••••••••
- Website accretepharma.com
- Legal Name Accrete Pharmaceuticals Private Limited
- Date of Incorporation 23 Jul, 2004
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹41.49 Cr
FY 2025 · +19% YoY
- Net Profit₹9.61 Cr
FY 2025 · 23% margin
- EBITDA₹14.60 Cr
FY 2025 · 35% margin
- Employee Count52
Associated legal entities of Accrete Pharma
Accrete Pharma operates through Accrete Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Accrete Pharmaceuticals Private Limited CIN U24239TG2004PTC043737 | Active | 23 Jul 2004 | Hyderabad, Telangana | ₹41.5 Cr | 52 | 4 | View details |
Products & Services of Accrete Pharma
Accrete Pharma offers a comprehensive portfolio of products and services, including Pazopanib Intermediates, Ibrutinib Intermediates, Imatinib Intermediates, and Lenalidomide Intermediates.
Intermediates used for manufacturing anti-cancer drug Pazopanib.
Intermediates for producing anti-cancer drug Ibrutinib.
Intermediates for anti-cancer drug Imatinib production.
Intermediates for anti-cancer drug Lenalidomide.
Board of directors of Accrete Pharmaceuticals Private Limited (Accrete Pharma)
Accrete Pharmaceuticals Private Limited is the primary company behind Accrete Pharma. The board of Accrete Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Sukarna Dodle, appointed in 2004. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sukarna Dodle DIN 02874451 | Director | 23 Jul 2004 | 22 yrs 2 mo | Accrete Pharmaceuticals Private Limited |
| Maheshwar Parsi DIN 03046970 | Director | 10 May 2010 | 16 yrs 5 mo | Accrete Pharmaceuticals Private Limited |
| Srinivas Aita DIN 02874447 | Director | 10 May 2010 | 16 yrs 5 mo | Accrete Pharmaceuticals Private Limited |
| Aileni Dhruva DIN 03087378 | Director | 14 May 2014 | 12 yrs 5 mo | Accrete Pharmaceuticals Private Limited |
People of Accrete Pharma
1 people are tracked at Accrete Pharma (1 in leadership); the tracked headcount is 52.
| Name | Role | Group |
|---|---|---|
DN Mohan Reddy | Founder, Director | Leadership |
Complete people profiles for Accrete Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Accrete Pharma
Figures of Accrete Pharmaceuticals Private Limited, the primary company behind Accrete Pharma, for FY 2025. Revenue was ₹41.49 Cr (+19% year on year). Net profit was ₹9.61 Cr (23% margin). EBITDA was ₹14.60 Cr (35% margin). Revenue has grown at a compounded annual rate of +13% over three years and +18% over five years.
- ₹41.49 CrRevenue · FY 2025 · +19% YoY
- ₹9.61 CrNet profit · 23% margin
- ₹14.60 CrEBITDA · 35% margin
- ₹4.50 CrPaid-up capital
- 52Employees (provident fund records)
- +13%Revenue CAGR, 3 years
- +18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Accrete Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Accrete Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Accrete Pharma
Accrete Pharma has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Accrete Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Accrete Pharma
The website of Accrete Pharma (accretepharma.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 1034% vs previous month
Top companies in Clinical Trials & Research Tech
2 companies that operate in the same segment as Accrete Pharma (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | USD 50.52 M | 902 | ||
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | USD 4.22 M | 228 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Accrete Pharma
Accrete Pharma was founded in 2007.
Accrete Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Accrete Pharma has 52 employees.
The primary company behind Accrete Pharma, Accrete Pharmaceuticals Private Limited, reported revenue of ₹41.49 Cr for FY 2025, up 19% year on year.
Accrete Pharmaceuticals Private Limited is an ISO-certified company that produces bulk drug intermediates, primarily for anti-cancer products. Based in Hyderabad, India, they focus on quality manufacturing, proper documentation, and customer satisfaction in the pharmaceutical industry. They operate a cGMP-compliant facility and prioritize advanced technologies for product development, supplying intermediates to other pharma companies while maintaining environmental standards.
Accrete Pharma's top competitors include Laurus Labs, Symbiotec and SeQuent.
Accrete Pharma offers Pazopanib Intermediates, Ibrutinib Intermediates, Imatinib Intermediates, and Lenalidomide Intermediates.
Accrete Pharma operates through Accrete Pharmaceuticals Private Limited.
The legal entities of Accrete Pharma currently have 4 directors, including Maheshwar Parsi, Srinivas Aita, Sukarna Dodle and others.